{"id":"W4385955746","doi":"10.1097/01.hs9.0000969496.68553.26","title":"P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Venetoclax; Obinutuzumab; Medicine; Bendamustine; Rituximab; Ibrutinib; Internal medicine; IGHV@; Chlorambucil; Fludarabine; Oncology; Population; Chronic lymphocytic leukemia; Cyclophosphamide; Leukemia; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001155769,0.0001787796,0.0002428829,0.0009811653,0.0003383044,0.0009273337,0.0003286848,0.000470951,0.001398655],"category_scores_gemma":[0.002821683,0.0001500981,0.000376156,0.001767524,0.0003822083,0.0008828465,0.00071039,0.0005189787,0.0002377273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006159258,"about_ca_system_score_gemma":0.0003990978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001728803,"about_ca_topic_score_gemma":0.001787827,"domain_scores_codex":[0.9992766,0.0002447246,0.0001120557,0.0001663852,0.0001037075,0.00009642665],"domain_scores_gemma":[0.9964663,0.0004106227,0.002571709,0.0001073421,0.0001659759,0.0002779879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005667224,0.00007961196,0.9954782,0.00003038279,0.00007313119,0.00005352821,0.0001001396,0.00007441025,0.00009137842,0.00002163069,0.0001793315,0.0032515],"study_design_scores_gemma":[0.00009169561,0.0006492362,0.9966441,0.00004124319,0.0001065731,0.0005371784,0.0004510095,0.0003054367,0.0001139065,0.00004796624,0.001000808,0.00001071766],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980505,0.0005278044,0.00007081887,0.00009045217,0.000004701979,0.00001508593,0.0007426201,0.000002692947,0.0004953427],"genre_scores_gemma":[0.9987225,0.0002330976,0.00006090528,0.00004781395,0.00001508,0.00002459374,0.0008006532,0.00000198952,0.00009325607],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001728803,"threshold_uncertainty_score":0.006112337,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04471865988519662,"score_gpt":0.3370424558678615,"score_spread":0.2923237959826649,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}